Issued Patents All Time
Showing 51–75 of 111 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 8017655 | Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents | Steven W. Andrews, Robert M. Burk, Michael E. Garst | 2011-09-13 |
| 7868032 | Prostamide receptor antagonists | Jenny W. Wang, Clive L. Cornell, Hans Fliri, Jose L. Martos, Simon N. Pettit | 2011-01-11 |
| 7868035 | Therapeutic esters | Robert M. Burk | 2011-01-11 |
| 7696235 | EP2 receptor agonists for treating glaucoma | June Chen | 2010-04-13 |
| 7612082 | Prostaglandin EP4 antagonists | Larry A. Wheeler, Michael E. Garst, Yanbin Liang, Achim H. Krauss, Robert M. Burk +4 more | 2009-11-03 |
| 7491383 | Compositions having enhanced pharmacokinetic characteristics | Gyorgy F. Ambrus | 2009-02-17 |
| 7351404 | Method of enhancing hair growth | Amanda M. VanDenburgh | 2008-04-01 |
| 7320871 | Human prostaglandin FP receptor variants and methods of using same | Yanbin Liang | 2008-01-22 |
| 7273883 | Prostaglandin EP4 antagonist | Achim H. Krauss, Yariv Donde, Robert M. Burk | 2007-09-25 |
| 7217725 | Prostaglandin D2 antagonist | Achim H. Krauss, Yariv Donde, Robert M. Burk | 2007-05-15 |
| 7198928 | Human COX-1 alternatively spliced variants and methods of using same | Yanbin Liang | 2007-04-03 |
| 7186744 | Prostamides for the treatment of glaucoma and related diseases | Robert M. Burk | 2007-03-06 |
| 7045634 | Prostamide receptor antagonists | Achim H. Krauss | 2006-05-16 |
| 7019149 | Thromboxane ligands without blood clotting side effects | Robert M. Burk, Achim H. Krauss | 2006-03-28 |
| 6956057 | EP4 agonists as agents for lowering intraocular pressure | Achim H. Krauss, Robert M. Burk, Mark Holoboski, Mari Posner | 2005-10-18 |
| 6911531 | Antibodies directed towards a novel human EP prostaglandin receptor | John W. Regan, Daniel W. Gil | 2005-06-28 |
| 6818779 | Thromboxane ligands without blood clotting side effects | Robert M. Burk, Achim H. Krauss | 2004-11-16 |
| 6713268 | Methods of identifying ocular hypotensive compounds having reduced hyperpigmentation | Licheng Shi, Achim H. Krauss, Clayton S. Spada, Sheila Mac Neil, Linda C. Smith-Thomas | 2004-03-30 |
| 6462077 | Thromboxane ligands without blood clotting side effects | Robert M. Burk, Achim H. Krauss | 2002-10-08 |
| 6403649 | Non-acidic cyclopentane heptanoic acid,2-cycloalkyl or arylalkyl derivatives as therapeutic agents | Steven W. Andrews, Robert M. Burk, Michael E. Garst | 2002-06-11 |
| 6395878 | Nucleic acid encoding a human EP prostaglandin receptor | John W. Regan, Daniel W. Gil | 2002-05-28 |
| 6395787 | Ocular hypotensive lipids | Helen Usansky, Steven W. Andrews, Robert M. Burk, June Chen, Achim H. Krauss +1 more | 2002-05-28 |
| 6277846 | Use of platelet activating factor antagonists as anti-pruritic agents | Linda S. Williams | 2001-08-21 |
| 6258844 | Cyclopentane (ene) oic acid, 2-alkenyl derivatives as therapeutic agents | Michael E. Garst, Michael B. Roof, Ming Fai Chan, Robert M. Burk, Todd S. Gac +1 more | 2001-07-10 |
| 6124353 | Method of treating ocular hypertension with 8-epi prostaglandins | — | 2000-09-26 |